Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
American chemical industry news
(page 13)
13 January 2026
Boehringer Ingelheim Advances IL-11 Inhibitor to Phase II for IPF
BI 765423, targeting IL-11, enters Phase IIa trials for IPF, aiming to improve lung function. Pre-clinical studies show promise in halting fibrosis and restoring lung functionality.
13 January 2026
BASF Acquires AgBiTech for Biological Insect Control
BASF to fully acquire AgBiTech by 2026, enhancing insect control solutions in Brazil with NPV technology, supporting sustainable agriculture and integrated pest management.
12 January 2026
NVIDIA and Lilly Launch AI Lab for Drug Discovery
The lab will invest $1B in AI to enhance drug discovery, integrating robotics and AI for continuous learning and improved medicine production.
12 January 2026
Boehringer Ingelheim and Jazz Pharmaceuticals Collaborate on HER2-Targeted Breast Cancer Therapy
Phase 1b study to test zongertinib and zanidatamab combo in HER2-positive breast cancer, aiming to improve outcomes with dual HER2-targeted therapy.
9 January 2026
Yara's 2026 Strategy: Resilient Earnings and Sustainable Growth
Yara aims for $600M cash flow growth by 2030, focusing on asset optimization, low-emission ammonia, and shareholder returns, while maintaining strict capital discipline.
9 January 2026
Kemira Acquires AquaBlue
The acquisition boosts Kemira's North American presence in industrial water treatment, integrating AquaBlue's expertise with Kemira's technologies.
How does the American chemical industry perform?
Find out with
chemXplore Alpha
Learn more
8 January 2026
SkyNRG Advances Project Wigeon with Key Environmental Approvals
Project Wigeon secures environmental approvals, moving to engineering phase. Facility to produce SAF from RNG, reducing emissions and boosting local economy by 2030.
8 January 2026
Johnson & Johnson Partners with U.S. Government to Enhance Medicine Access and Reduce Costs
Agreement with U.S. government to lower drug costs. $55B investment in U.S. manufacturing, including new facilities in Pennsylvania and North Carolina, creating thousands of jobs.
8 January 2026
Lilly's Taltz and Zepbound Show Superior Results in Psoriatic Arthritis and Obesity Trial
The trial showed Taltz and Zepbound together improved psoriatic arthritis and weight loss more than Taltz alone, with mild to moderate side effects.
8 January 2026
Takeda and Halozyme Collaborate on Vedolizumab
The partnership aims to enhance vedolizumab delivery for IBD treatment, improving patient care and expanding access with ENHANZE technology.
8 January 2026
SABIC Divests European Petrochemicals and Americas/Europe Engineering Thermoplastics for $950 Million
The divestments aim to optimize the portfolio, enhance cash flow, and focus on high-margin markets, while maintaining strategic access and customer service.
7 January 2026
Borouge Implements AI Operations at Ruwais for Enhanced Efficiency
AI operations at Ruwais boost efficiency by 20%, cut downtime by 20%, and reduce costs by 15%, enhancing safety and sustainability. Part of a $575M value generation program.
7 January 2026
Veolia Issues €2.5 Billion in Bonds
Veolia's bond issuance attracted 570+ orders, peaking at €10.5B. Strong demand led to favorable terms, highlighting investor confidence in Veolia's growth and financial stability.
7 January 2026
Lilly Acquires Ventyx Biosciences to Enhance Inflammatory Disease Therapies
Ventyx's small molecule pipeline targets chronic inflammation in cardiometabolic, neurodegenerative, and inflammatory diseases, aiming for improved efficacy and safety.
7 January 2026
Topsoe Announces CEO Transition: Scaltritti to Succeed Baan
Baan steps down as CEO in 2026. Scaltritti, current CCO, will succeed him. Baan led significant transformations, including green hydrogen and sustainable fuel initiatives.
7 January 2026
Corteva and bp Form Etlas Biofuel Feedstock Venture
Etlas will produce biofuel feedstocks from crops, aiming for 1M tonnes annually by mid-2030s, supporting SAF and RD demand growth without extra land use.
7 January 2026
Merck Finalizes Cidara Therapeutics Acquisition
Merck acquires Cidara, enhancing its respiratory portfolio with CD388, a long-acting antiviral for influenza prevention, impacting 2026 R&D expenses and EPS.
7 January 2026
Sunrise Wind Challenges Lease Suspension in Court
Sunrise Wind seeks a preliminary injunction against a lease suspension, citing legal violations and project delays, impacting energy supply and jobs.
6 January 2026
LibertyStream Produces Spec-Compliant Lithium Carbonate in Texas
Consistent lithium carbonate production validated; customer sampling underway. Plans for bulk sampling and offtake discussions aim for commercial volumes by 2027.
6 January 2026
Johnson & Johnson Reports Positive Phase 2 Results for Nipocalimab in SLE Study
Nipocalimab shows promise in reducing SLE activity, meeting primary and secondary endpoints in Phase 2b JASMINE study, with a consistent safety profile. Phase 3 program initiated.
6 January 2026
Johnson & Johnson Seeks EMA Approval for TECVAYLI and DARZALEX Combo in Relapsed Multiple Myeloma
The EMA application is based on Phase 3 data showing improved survival in relapsed multiple myeloma with TECVAYLI and DARZALEX, with similar adverse event rates to standard care.
5 January 2026
TechnipFMC Secures iEPCI™ Contract for bp's Tiber Project
TechnipFMC awarded iEPCI™ contract for bp's Tiber project, leveraging Kaskida's 20K psi technology for efficient, collaborative greenfield development in the Gulf of America.
5 January 2026
Takeda and Protagonist Submit NDA for Rusfertide in Polycythemia Vera Treatment
Rusfertide shows promise in controlling hematocrit and reducing phlebotomy in PV patients, meeting key endpoints in Phase 3 VERIFY study.
2 January 2026
Technip Energies Acquires Ecovyst's Advanced Materials & Catalysts Business
The acquisition enhances Technip Energies' catalyst capabilities, supports growth in sustainable fuels, and adds 330 employees, boosting earnings and value creation.
2 January 2026
Brightmark RNG Holdings Delivers First Gas at 10 Midwest Projects
Brightmark's RNG projects reduce emissions, support local economies, and highlight renewable natural gas potential through anaerobic digestion with farmers.
29 December 2025
Huntsman Names Amy Smedley as EVP and General Counsel
Amy Smedley rejoins Huntsman as EVP, General Counsel & Secretary, succeeding David Stryker. She brings extensive legal experience from Savage Companies and her previous tenure at Huntsman.
29 December 2025
OCI Global's Beaumont Facility Begins Ammonia Production
The Beaumont facility in Texas has started ammonia production after systems testing, with handover to Woodside Energy expected in early 2026.
22 December 2025
Technip Energies Secures Equipment Orders from Commonwealth LNG
Technip Energies advances Commonwealth LNG project with key equipment orders, supporting modular construction and accelerating progress towards a 2026 investment decision.
22 December 2025
FDA Approves Novo Nordisk's Oral Wegovy for Adult Weight Loss
FDA approves Wegovy pill, the first oral GLP-1 for weight loss, showing ~17% loss in trials. Available January at $149/month, it also reduces cardiovascular risks in adults with obesity.
22 December 2025
Novo Nordisk: FDA Approves Wegovy® Oral Pill for Weight Management
Wegovy® pill, an oral GLP-1, shows 16.6% weight loss in trials. Launch expected in the US by January 2026. Approval based on OASIS and SELECT trials.
← Previous
Next →
